7Baggers
 Roche launches tender offer for 89bio  MarketScreener Thu, 02 Oct 2025 05:50:21 GMT
 Roche Initiates Tender Offer for 89bio (ETNB) in $3.5B Acquisiti  GuruFocus Wed, 01 Oct 2025 22:24:26 GMT
 89bio to participate in upcoming investor conferences  富途牛牛 Mon, 29 Sep 2025 16:30:54 GMT
 roche deal to buy 89bio boosts mash space  MSN Thu, 25 Sep 2025 13:06:17 GMT
 89bio $etnb shares acquired by voya investment management llc  MarketBeat Thu, 25 Sep 2025 07:20:25 GMT
 89bio (nasdaq:etnb) downgraded by hc wainwright to "neutral"  MarketBeat Wed, 24 Sep 2025 10:34:02 GMT
 rhumbline advisers increases stake in 89bio $etnb  MarketBeat Wed, 24 Sep 2025 07:16:46 GMT
 roche deal to buy 89bio boosts mash space  MSN Wed, 24 Sep 2025 06:26:06 GMT
 89bio (nasdaq:etnb) downgraded by wolfe research to peer perform  MarketBeat Wed, 24 Sep 2025 01:30:00 GMT
 rhumbline advisers increases stake in 89bio $etnb  MarketBeat Tue, 23 Sep 2025 17:37:30 GMT
 89bio (nasdaq:etnb) downgraded by hc wainwright to "neutral"  MarketBeat Tue, 23 Sep 2025 17:37:30 GMT
 wolfe research downgrades 89bio(etnb.us) to hold rating  富途牛牛 Tue, 23 Sep 2025 14:42:49 GMT
 89bio (nasdaq:etnb) sets new 1-year high - should you buy?  MarketBeat Tue, 23 Sep 2025 10:48:23 GMT
 hc wainwright downgrades 89bio (nasdaq:etnb) to neutral  MarketBeat Tue, 23 Sep 2025 10:48:23 GMT
 rhumbline advisers acquires 22,158 shares of 89bio $etnb  MarketBeat Tue, 23 Sep 2025 10:09:48 GMT
 Roche to acquire 89bio, will get pegozafermin for MASH in deal  Liver Disease News Mon, 22 Sep 2025 18:43:59 GMT
 89bio (nasdaq:etnb) sets new 52-week high - here's what happened  MarketBeat Mon, 22 Sep 2025 08:19:06 GMT
 Roche To Buy 89bio For Up To $3.5 Billion  Pulse 2.0 Mon, 22 Sep 2025 07:00:00 GMT
 89bio (nasdaq:etnb) sets new 1-year high - should you buy?  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 rhumbline advisers acquires 22,158 shares of 89bio $etnb  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 hc wainwright downgrades 89bio (nasdaq:etnb) to neutral  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 89bio $etnb shares sold by harbor capital advisors inc.  MarketBeat Mon, 22 Sep 2025 04:24:13 GMT
 rhumbline advisers purchases 22,158 shares of 89bio $etnb  MarketBeat Sun, 21 Sep 2025 07:17:47 GMT
 rhumbline advisers has $1.11 million holdings in 89bio $etnb  MarketBeat Sun, 21 Sep 2025 07:17:47 GMT
 89bio $etnb shares sold by harbor capital advisors inc.  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 89bio (nasdaq:etnb) sets new 52-week high - here's what happened  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 89bio (nasdaq:etnb) sees large volume increase - still a buy?  MarketBeat Sat, 20 Sep 2025 16:26:00 GMT
 89bio (nasdaq:etnb) sees strong trading volume - here's why  MarketBeat Sat, 20 Sep 2025 16:26:00 GMT
 89bio (nasdaq:etnb) sees strong trading volume - still a buy?  MarketBeat Sat, 20 Sep 2025 16:26:00 GMT
 hc wainwright downgrades 89bio (nasdaq:etnb) to neutral  MarketBeat Sat, 20 Sep 2025 12:17:46 GMT
 hc wainwright reaffirms neutral rating for 89bio (nasdaq:etnb)  MarketBeat Sat, 20 Sep 2025 12:17:46 GMT
 wolfe research downgrades 89bio (nasdaq:etnb) to peer perform  MarketBeat Sat, 20 Sep 2025 12:13:34 GMT
 goldman sachs group inc. has $7.24 million holdings in 89bio $etnb  MarketBeat Sat, 20 Sep 2025 07:07:07 GMT
 harbor capital advisors inc. lowers stock position in 89bio $etnb  MarketBeat Sat, 20 Sep 2025 07:07:05 GMT
 89bio (nasdaq:etnb) given "sell (d-)" rating at weiss ratings  MarketBeat Sat, 20 Sep 2025 07:07:05 GMT
 89bio $etnb shares sold by harbor capital advisors inc.  MarketBeat Sat, 20 Sep 2025 07:00:00 GMT
 roche to acquire 89bio in $3.5b deal  Indian Pharma Post Sat, 20 Sep 2025 06:34:36 GMT
 89bio stock price, quotes and forecasts | nasdaq:etnb  Benzinga Fri, 19 Sep 2025 17:32:40 GMT
 89bio (nasdaq:etnb) reaches new 12-month high - should you buy?  MarketBeat Fri, 19 Sep 2025 15:46:36 GMT
 89bio (nasdaq:etnb) sets new 12-month high - here's why  MarketBeat Fri, 19 Sep 2025 15:46:36 GMT
 89bio (nasdaq:etnb) hits new 52-week high - time to buy?  MarketBeat Fri, 19 Sep 2025 15:46:36 GMT
 raymond james downgrades 89bio stock rating on roche acquisition  Investing.com Fri, 19 Sep 2025 12:28:53 GMT
 hc wainwright & co. downgrades 89bio (etnb) to neutral rating |  GuruFocus Fri, 19 Sep 2025 12:18:01 GMT
 switzerland: roche to acquire 89bio in deal of up to us$3.5bn  Investors in Healthcare Fri, 19 Sep 2025 09:00:43 GMT
 Roche Buys 89Bio, Novartis Doubles Down on Monte Rosa, & aTyr Flames Out  Timmerman Report Fri, 19 Sep 2025 08:22:51 GMT
 roche to acquire liver drug developer 89bio for up to $3.5 billion  1470 & 100.3 WMBD Fri, 19 Sep 2025 07:56:14 GMT
 Roche to Acquire 89Bio in $3.5 Billion Deal  CHEManager Fri, 19 Sep 2025 07:00:00 GMT
 Roche to enter FGF21 space with $2.4B buyout of MASH biotech 89bio  Endpoints News Fri, 19 Sep 2025 07:00:00 GMT
 goldman sachs group inc. has $7.24 million holdings in 89bio $etnb  MarketBeat Fri, 19 Sep 2025 07:00:00 GMT
 89bio (nasdaq:etnb) given "sell (d-)" rating at weiss ratings  MarketBeat Fri, 19 Sep 2025 07:00:00 GMT
 89bio $etnb shares purchased by woodline partners lp  MarketBeat Fri, 19 Sep 2025 06:27:13 GMT
 global pharma firm roche to buy us biotech 89bio for up to $3.5b  Tech in Asia Fri, 19 Sep 2025 06:07:00 GMT
 89bio $etnb shares purchased by goldman sachs group inc.  MarketBeat Fri, 19 Sep 2025 05:28:06 GMT
 roche bets on liver disease with $2.4 billion 89bio deal  Finimize Fri, 19 Sep 2025 03:48:46 GMT
 jacobs levy equity management inc. invests $719,000 in 89bio $etnb  MarketBeat Fri, 19 Sep 2025 03:30:36 GMT
 89bio (nasdaq:etnb) given sell (d-) rating at weiss ratings  MarketBeat Fri, 19 Sep 2025 03:28:57 GMT
 roche to acquire 89bio in us$3.5 billion deal to bolster metabolic disease pipeline  Proactive financial news Fri, 19 Sep 2025 02:45:00 GMT
 89bio (nasdaq:etnb) given sell (d-) rating at weiss ratings  MarketBeat Thu, 18 Sep 2025 22:27:19 GMT
 Roche Makes Major MASH Bid, Offering $2.4bn For 89bio  insights.citeline.com Thu, 18 Sep 2025 21:58:10 GMT
 roche scoops up 89bio in a $2.4 billion deal  Finimize Thu, 18 Sep 2025 20:51:44 GMT
 roche digs into metabolic disease with another big buyout  Investor's Business Daily Thu, 18 Sep 2025 20:09:00 GMT
 jacobs levy equity management inc. invests $719,000 in 89bio $etnb  MarketBeat Thu, 18 Sep 2025 19:27:00 GMT
 roche to buy 89bio for up to $3.5 billion  MSN Thu, 18 Sep 2025 19:19:11 GMT
 roche to buy 89bio in $3.5 billion deal  USA Herald Thu, 18 Sep 2025 18:13:59 GMT
 harbor capital advisors inc. lowers stock position in 89bio $etnb  MarketBeat Thu, 18 Sep 2025 18:11:15 GMT
 roche bets on liver disease with $2.4 billion 89bio deal  Finimize Thu, 18 Sep 2025 16:32:00 GMT
 Roche to Acquire 89bio and Phase 3 MASH Candidate in Potential $3.5B Deal  Contract Pharma Thu, 18 Sep 2025 15:46:24 GMT
 Roche deal to buy 89bio boosts MASH space  MSN Thu, 18 Sep 2025 15:00:54 GMT
 roche (rhhby) to acquire 89bio for $3.5 billion to bolster obesi  GuruFocus Thu, 18 Sep 2025 14:39:01 GMT
 89bio stock surge: time to invest?  timothysykes.com Thu, 18 Sep 2025 13:19:00 GMT
 roche pays $3.5 billion for 89bio and promising mash drug  European Pharmaceutical Review Thu, 18 Sep 2025 12:09:42 GMT
 roche to buy us biotech 89bio in $3.5bn deal  Proactive Investors Thu, 18 Sep 2025 12:04:00 GMT
 first look: roche's acquisition of 89bio and novo nordisk's ozem  GuruFocus Thu, 18 Sep 2025 11:53:10 GMT
 roche to enter fgf21 space with $2.4b buyout of mash biotech 89bio  Endpoints News Thu, 18 Sep 2025 11:04:30 GMT
 roche to buy nasdaq-listed 89bio for up $3.5bn  Sharecast.com Thu, 18 Sep 2025 10:41:03 GMT
 goldman sachs group inc. raises stake in 89bio $etnb  MarketBeat Thu, 18 Sep 2025 10:28:04 GMT
 roche to buy 89bio for up to $3.5b  Globes - Israel Business News Thu, 18 Sep 2025 09:33:52 GMT
 roche to acquire 89bio for up to $3.5 billion in liver disease push  Investing.com Nigeria Thu, 18 Sep 2025 09:27:41 GMT
 89bio soars on roche's deal to buy co for up to $3.5 bln  TradingView Thu, 18 Sep 2025 08:56:33 GMT
 roche to buy us biotech firm 89bio for up to $3.5 billion  Yahoo Finance Thu, 18 Sep 2025 08:23:51 GMT
 89bio $etnb stake cut by harbor capital advisors inc.  MarketBeat Thu, 18 Sep 2025 08:04:39 GMT
 harbor capital advisors inc. decreases holdings in 89bio $etnb  MarketBeat Thu, 18 Sep 2025 08:04:39 GMT
 roche to acquire liver drug developer 89bio for €2.4bn  RTE.ie Thu, 18 Sep 2025 07:44:52 GMT
 switzerland’s roche strikes $3.5bn deal to buy us drugmaker 89bio  Financial Times Thu, 18 Sep 2025 07:18:45 GMT
 roche to buy biopharmaceutical firm 89bio in $3.5bn deal  Moneyweb Thu, 18 Sep 2025 07:18:00 GMT
 roche (otcqx:rhhby) to acquire 89bio (etnb) in $2.4 billion deal  GuruFocus Thu, 18 Sep 2025 07:01:05 GMT
 Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion  The Wall Street Journal Thu, 18 Sep 2025 07:00:00 GMT
 Roche dives into MASH with $2.4B deal for 89bio  BioPharma Dive Thu, 18 Sep 2025 07:00:00 GMT
 Roche becomes MASH player via $3.5B deal for 89bio and its phase 3 drug  Fierce Biotech Thu, 18 Sep 2025 07:00:00 GMT
 Roche Makes Major MASH Move With $3.5B 89bio Buy  BioSpace Thu, 18 Sep 2025 07:00:00 GMT
 Roche to buy 89bio in deal worth up to $3.5B, picking up MASH drug  statnews.com Thu, 18 Sep 2025 07:00:00 GMT
 RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline  Yahoo Finance Thu, 18 Sep 2025 07:00:00 GMT
 Roche to buy metabolic biotech 89bio for up to $3.5B  Axios Thu, 18 Sep 2025 07:00:00 GMT
 Roche to pay $2.4B to acquire 89bio and its MASH hopeful pegozafermin  FirstWord Pharma Thu, 18 Sep 2025 07:00:00 GMT
 Roche signs agreement to acquire 89bio in $2.4bn deal  Yahoo Finance Thu, 18 Sep 2025 07:00:00 GMT
 Roche pays $3.5bn for 89bio and its potential best-in-disease treatment MASH drug  European Pharmaceutical Review Thu, 18 Sep 2025 07:00:00 GMT
 Roche acquires US biotech 89bio for $3.5bn  European Medical Journal Thu, 18 Sep 2025 07:00:00 GMT
 89bio To Be Bought By Roche For Around $3.5 Bln  Nasdaq Thu, 18 Sep 2025 07:00:00 GMT
 Roche punts up to $3.5B to acquire 89bio  The Pharma Letter Thu, 18 Sep 2025 07:00:00 GMT
 Roche Digs Into Obesity-Tied Diseases With $3.5 Billion 89bio Buyout  Investor's Business Daily Thu, 18 Sep 2025 07:00:00 GMT
 Swiss pharma firm Roche to acquire US-based biotech firm 89bio for $3.5B  Anadolu Ajansı Thu, 18 Sep 2025 07:00:00 GMT
 Roche to Buy Biopharmceutical Firm 89bio in $3.5 Billion Deal  Bloomberg.com Thu, 18 Sep 2025 07:00:00 GMT
 Roche to acquire 89bio in a deal worth up to US$3.5bn  PMLiVE Thu, 18 Sep 2025 07:00:00 GMT
 MASH dash speeds up as Roche acquires 89bio for up to $3.5B  BioWorld MedTech Thu, 18 Sep 2025 07:00:00 GMT
 Roche deal to buy 89bio boosts MASH space (ETNB:NASDAQ)  Seeking Alpha Thu, 18 Sep 2025 07:00:00 GMT
 Roche acquires 89bio for US$3.5bn  European Biotechnology Magazine Thu, 18 Sep 2025 07:00:00 GMT
 Roche buys US firm 89bio for up to $3.5 billion  swissinfo.ch Thu, 18 Sep 2025 07:00:00 GMT
 Why Did 89bio Stock Nearly Double In Value Today?  MSN Thu, 18 Sep 2025 07:00:00 GMT
 Roche poised to buy MASH drug developer 89bio for $3.5bn  pharmaphorum Thu, 18 Sep 2025 07:00:00 GMT
 recon: roche to buy mash biotech 89bio for $2.4b; kennedy’s acip weighs changes to childhood vaccines  Regulatory Affairs Professionals Society | RAPS Thu, 18 Sep 2025 07:00:00 GMT
 89bio, inc. announces agreement to be acquired by roche  Yahoo Finance Thu, 18 Sep 2025 07:00:00 GMT
 roche acquires 89bio stock for $14.50 per share plus cvr  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 roche enters into definitive merger agreement to acquire 89bio  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 is etnb stock a bargain or a risk?  StocksToTrade Thu, 18 Sep 2025 07:00:00 GMT
 89bio announces merger agreement with roche  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 89bio stock reaches 52-week high at $14.97 despite yearly dip  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 roche buys us biotech 89bio for usd 3.5bn  medwatch.com Thu, 18 Sep 2025 07:00:00 GMT
 roche to acquire 89bio for up to usd 3.5 billion  Medical Dialogues Thu, 18 Sep 2025 07:00:00 GMT
 89bio $etnb shares purchased by woodline partners lp  MarketBeat Thu, 18 Sep 2025 07:00:00 GMT
 swiss pharma giant roche to buy us-listed 89bio for $2.4 bln in cash  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 roche to acquire 89bio (etnb) in $3.5 billion deal  GuruFocus Thu, 18 Sep 2025 07:00:00 GMT
 roche to acquire clinical-stage company 89bio in $2.4 billion deal  MarketScreener Thu, 18 Sep 2025 05:43:10 GMT
 roche to acquire 89bio in $3.5b deal  breakingthenews.net Thu, 18 Sep 2025 05:29:00 GMT

89bio, Inc
(NASDAQ:ETNB) 

ETNB stock logo

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalc...

Founded: 2018
IPO Price: $16 (Nov 11, 2019)
Full Time Employees: 25
CEO: Rohan Palekar  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends